Fig. 6

Pearson correlation analysis of ∆BMI, ∆CRP, ∆IL-6, ∆TNF-α, ∆AGEs with ∆ EPA, ∆EAA, ∆EMA, ∆ETF in the MET-DUL group (r). MET-DUL Metformin combined with dulaglutide treatment group; BMI body mass index; CRP C-reactive protein; TNF-α tumour necrosis factor-α; IL-6 interleukin-6; AGEs advanced glycation end products; EPA proliferative ability of endothelial progenitor cells; EAA adhesion ability of endothelial progenitor cells; EMA migration ability of endothelial progenitor cells; ETF tubule forming ability of endothelial progenitor cells